118 related articles for article (PubMed ID: 9472305)
1. Treatment of human Mansonella streptocerca infection with ivermectin.
Fischer P; Bamuhiiga J; Büttner DW
Trop Med Int Health; 1997 Feb; 2(2):191-9. PubMed ID: 9472305
[TBL] [Abstract][Full Text] [Related]
2. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin.
Fischer P; Tukesiga E; Büttner DW
J Infect Dis; 1999 Oct; 180(4):1403-5. PubMed ID: 10479183
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and diagnosis of Mansonella streptocerca in Uganda.
Fischer P; Bamuhiiga J; Büttner DW
Acta Trop; 1997 Jan; 63(1):43-55. PubMed ID: 9083584
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin-related adverse clinical events in patients treated for Mansonella ozzardi infections.
Krolewiecki AJ; Cajal SP; Villalpando C; Gil JF
Rev Argent Microbiol; 2011; 43(1):48-50. PubMed ID: 21491068
[TBL] [Abstract][Full Text] [Related]
5. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
6. Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection.
Nutman TB; Nash TE; Ottesen EA
J Infect Dis; 1987 Oct; 156(4):662-5. PubMed ID: 3305722
[No Abstract] [Full Text] [Related]
7. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay.
Fischer P; Büttner DW; Bamuhiiga J; Williams SA
Am J Trop Med Hyg; 1998 Jun; 58(6):816-20. PubMed ID: 9660471
[TBL] [Abstract][Full Text] [Related]
8. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients.
Schulz-Key H; Albrecht W; Heuschkel C; Soboslay PT; Banla M; Görgen H
Trans R Soc Trop Med Hyg; 1993; 87(2):227-9. PubMed ID: 8337736
[TBL] [Abstract][Full Text] [Related]
10. Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of
de Almeida Basano S; de Souza Almeida Aranha Camargo J; Fontes G; Pereira AR; Medeiros JF; de Oliveira Laudisse MC; de Godoi Mattos Ferreira R; Camargo LMA
Am J Trop Med Hyg; 2018 Mar; 98(3):786-790. PubMed ID: 29313486
[TBL] [Abstract][Full Text] [Related]
11. Immunohistological studies on macrophages in lymph nodes of onchocerciasis patients after treatment with ivermectin.
Knab J; Darge K; Büttner DW
Trop Med Int Health; 1997 Dec; 2(12):1156-69. PubMed ID: 9438472
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
[TBL] [Abstract][Full Text] [Related]
13. Sustained clearance of Mansonella ozzardi infection after treatment with ivermectin in the Brazilian Amazon.
Basano Sde A; Fontes G; Medeiros JF; Aranha Camargo JS; Souza Vera LJ; Parente Araújo MP; Pires Parente MS; Mattos Ferreira Rde G; Barreto Crispim Pd; Aranha Camargo LM
Am J Trop Med Hyg; 2014 Jun; 90(6):1170-5. PubMed ID: 24710613
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis.
Bregani ER; Rovellini A; Mbaïdoum N; Magnini MG
Trans R Soc Trop Med Hyg; 2006 May; 100(5):458-63. PubMed ID: 16257021
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind field trial of ivermectin alone and in combination with albendazole for the treatment of Mansonella perstans infections in Uganda.
Asio SM; Simonsen PE; Onapa AW
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):274-9. PubMed ID: 19081121
[TBL] [Abstract][Full Text] [Related]
16. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
[TBL] [Abstract][Full Text] [Related]
17. Effects of thiabendazole in Mansonella perstans filariasis.
Bregani ER; Rovellini A; Tarsia P
Parassitologia; 2003 Dec; 45(3-4):151-3. PubMed ID: 15267104
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
Darge K; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
[TBL] [Abstract][Full Text] [Related]
19. Update on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin.
Wanji S; Tayong DB; Layland LE; Datchoua Poutcheu FR; Ndongmo WP; Kengne-Ouafo JA; Ritter M; Amvongo-Adjia N; Fombad FF; Njeshi CN; Nkwescheu AS; Enyong PA; Hoerauf A
Parasit Vectors; 2016 May; 9(1):311. PubMed ID: 27245442
[TBL] [Abstract][Full Text] [Related]
20. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
Richard-Lenoble D; Kombila M; Rupp EA; Pappayliou ES; Gaxotte P; Nguiri C; Aziz MA
Am J Trop Med Hyg; 1988 Nov; 39(5):480-3. PubMed ID: 3195695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
